On November 1, the Bureau of Workers’ Compensation began reimbursing pharmacies for dispensing a drug disposal system to patients receiving an opioid prescription for the first time in the last 12 months. The Bureau’s October 2019 issue of the Provider eNews includes an overview of the program.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
On November 1, the Bureau of Workers’ Compensation began reimbursing pharmacies for dispensing a drug disposal system to patients receiving an opioid prescription for the first time in the last 12 months. The Bureau’s October 2019 issue of the Provider eNews includes an overview of the program.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Department of Medicaid (ODM) announced they will implement a single preferred drug list (PDL) beginning Jan. 1, 2020. The move is one in a series of reforms ODM is planning that are meant to increase transparency in the system for both patients and providers. Click here for the PDL and more information on this and other reforms ODM is considering.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
NACDS reminds members that the Ohio Department of Medicaid has published an RFI seeking providers’ input on Managed Care Procurement and encourages members to respond to the RFI and share their company’s experiences with and suggestions for improving the Managed Care system. Currently, there is no due date for submissions; it will be announced two weeks prior to closing.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Pharmacy will not begin enforcing USP Chapter <800> on Sunday, December 1. The Board will discuss the effective date of updated compounding rules that require adherence to USP <800> at its November meeting.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Pharmacy issued updated guidance documents effective May 13 related to dispensing naltrexone without a prescription and dispensing of emergency supply of medication without a prescription.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Pharmacy published guidance reminding dispensers that effective Tuesday, March 19, they will be required to report certain products containing naltrexone to the Ohio Automated Rx Reporting System (OARRS). The guidance encourages dispensers to work with their vendors to ensure any system updates that may be needed are in place by the deadline.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
NACDS submitted comments to the Board of Pharmacy on a proposed rule modifying the requirements for reporting to the state’s prescription drug monitoring program (PDMP). Specifically, NACDS asked the Board to clarify that pharmacies are required to submit a patient’s phone number as the patient identifier where it is available. Additionally, NACDS asked the Board to change a requirement that pharmacies notify the Board of PDMP submission errors to requiring such a notification only where the submission error cannot be corrected within seven days.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
On April 4, the Department of Insurance issued Bulletin 2018-02, prohibiting insurers and Pharmacy Benefit Managers from:
The bulletin was effective upon release.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.